research The Multisystem Impact of Long COVID: A Comprehensive Review
Long COVID causes a wide range of long-lasting symptoms that change over time and are hard to diagnose and treat.
Search
for
Sort by
Research
990-1000 / 1000+ results
research Sex Hormones in COVID-19 Severity: The Quest for Evidence and Influence Mechanisms
Sex hormones may affect COVID-19 severity and outcomes.
research Characteristics of hair loss in COVID-19 patients in Thailand.
COVID-19 patients in Thailand typically started losing hair about 30 days after infection, with women experiencing more severe hair loss.
research Letter on: “Platelet-Rich Plasma for Treatment of Hair Loss Improves Patient-Reported Quality of Life”
Platelet-rich plasma treatment for hair loss may improve patients' quality of life.
research Alopecia: An OVerall Review Including Causes, COVID-19, Diet, And Treatments
The document concludes that alopecia is an incurable autoimmune disease with various treatments and that diet, as well as COVID-19, may impact it.
research Associations of telogen effluvium with coronavirus disease 2019 and research progress in its diagnosis and treatment
COVID-19 may cause common hair loss due to stress, immune response, medications, and other health issues.
research The Role of Neurorehabilitation in Post-COVID-19 Syndrome
Tailored neurorehabilitation programs improve life quality for post-COVID-19 patients.
research Three years on, COVID-19 and the skin: long-term impacts, emerging trends and clinical practice
COVID-19 can cause long-term skin problems and has changed how skin doctors work.
research Incidence and probable risk factors of post COVID syndrome among COVID-19 patients in urban population of North Kerala: a 6 months cohort study
Older people with severe COVID-19, especially those with certain health conditions, are more likely to experience post-COVID syndrome.
research Hormone replacement therapy and COVID-19 outcomes in solid organ transplant recipients compared with the general population
Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.